Axogen Inc vs Starbucks Corp — how do they compare? Axogen Inc trades at $49.66 (market cap $2.61B), while Starbucks Corp trades at $108.48 (market cap $121.59B). The key difference: Starbucks Corp is far larger — about 46.6× Axogen Inc's market cap, and Starbucks Corp pays a 2.33% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| AXGN | SBUX | |
|---|---|---|
Market Cap | $2.61B | $121.59B |
Sector | Technology | Consumer Cyclical |
52-Week High | $48.48 | $108.37 |
52-Week Low | $14.16 | $78.46 |
Enterprise Value | $2.52B | $140.42B |
Volume | — | 7,493,833 |
Dividend Yield | — | 2.33% |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $49.67, up 3.01% with strong technical momentum. The stock shows bullish moving average signals despite recent earnings misses. Q2 2026 revenue grew 23.1% to $69.7M with raised full-year guidance to $279M, though net margins remain negative at -13.36%. Analyst consensus is strongly bullish with 16 buy ratings and $54.33 price target.
Growth prospects appear strong with expanding nerve care platform and reimbursement wins, but profitability challenges and high valuation multiples present risks. The stock trades near resistance at $50 with RSI indicating overbought conditions, suggesting potential near-term consolidation before further upside.
Starbucks (SBUX) trades at $108.03, up 3.23% with strong technical momentum and bullish moving average signals. The company shows improving fundamentals with recent earnings beats and raised 2026 guidance, though valuation remains elevated at a P/E of 61.65. Recent news highlights a successful turnaround strategy under CEO Brian Niccol, with traffic recovery and margin expansion driving optimism.
The outlook remains positive with analyst consensus pointing to $113.60 price target, though high valuation and execution risks require monitoring. Key opportunities include sustained traffic growth and cost efficiency initiatives, while risks involve premium pricing sensitivity and competitive pressures in the coffee retail space.
Trailing returns across standard periods
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →Starbucks Corporation retails, roasts, and provides its own brand of specialty coffee. The Company operates retail locations worldwide and sells whole bean coffees through its sales group, direct response business, supermarkets, and on the world wide web. Starbucks also produces and sells bottled coffee drinks and a line of ice creams.
Read more on SBUX →